These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29444608)

  • 1. Acute autoimmune myocarditis and hepatitis due to ipilimumab monotherapy for malignant melanoma.
    Samara Y; Yu CL; Dasanu CA
    J Oncol Pharm Pract; 2019 Jun; 25(4):966-968. PubMed ID: 29444608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal myocarditis and rhabdomyositis in a patient with stage IV melanoma treated with combined ipilimumab and nivolumab.
    Saibil SD; Bonilla L; Majeed H; Sotov V; Hogg D; Chappell MA; Cybulsky M; Butler MO
    Curr Oncol; 2019 Jun; 26(3):e418-e421. PubMed ID: 31285688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune meningoencephalitis in a melanoma patient treated with ipilimumab.
    Choe JH; Andonian BJ; Kim GJ; Salama AK
    Immunotherapy; 2016 Oct; 8(10):1163-7. PubMed ID: 27605066
    [No Abstract]   [Full Text] [Related]  

  • 4. Survival After Fulminant Myocarditis Induced by Immune-Checkpoint Inhibitors.
    Arangalage D; Delyon J; Lermuzeaux M; Ekpe K; Ederhy S; Pages C; Lebbé C
    Ann Intern Med; 2017 Nov; 167(9):683-684. PubMed ID: 28869988
    [No Abstract]   [Full Text] [Related]  

  • 5. Late-onset pericardial tamponade, bilateral pleural effusions and recurrent immune monoarthritis induced by ipilimumab use for metastatic melanoma.
    Dasanu CA; Jen T; Skulski R
    J Oncol Pharm Pract; 2017 Apr; 23(3):231-234. PubMed ID: 26946531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination Nivolumab/Ipilimumab Immunotherapy For Melanoma With Subsequent Unexpected Cardiac Arrest: A Case Report and Review of Literature.
    Khoury ZH; Hausner PF; Idzik-Starr CL; Frykenberg MRA; Brooks JK; Dyalram D; Basile JR; Younis RH
    J Immunother; 2019 Oct; 42(8):313-317. PubMed ID: 31206394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory treatment of immune checkpoint inhibitor-induced myocarditis: Pathway toward precision-based therapy.
    Balanescu DV; Donisan T; Palaskas N; Lopez-Mattei J; Kim PY; Buja LM; McNamara DM; Kobashigawa JA; Durand JB; Iliescu CA
    Cardiovasc Pathol; 2020; 47():107211. PubMed ID: 32268262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical Myocarditis After Combination Immune Checkpoint Inhibitor Therapy.
    Giblin GT; Dennehy C; Featherstone H; Clarke R; Murphy L; Timlin D; O'Keane C; Mulligan N; Kelly CM; Joyce E
    Circ Heart Fail; 2021 Feb; 14(2):e007524. PubMed ID: 33478241
    [No Abstract]   [Full Text] [Related]  

  • 9. Autoimmune Bell's Palsy Following Immunotherapy For Metastatic Melanoma: A Report of 2 Cases.
    Zieman D; Frankel AE
    J Immunother; 2019 Oct; 42(8):318-320. PubMed ID: 31318723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory demyelinating polyneuropathy versus leptomeningeal disease following Ipilimumab.
    Cafuir L; Lawson D; Desai N; Kesner V; Voloschin A
    J Immunother Cancer; 2018 Jan; 6(1):11. PubMed ID: 29382383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune checkpoint inhibitors myocarditis: not all cases are clinically patent.
    Thibault C; Vano Y; Soulat G; Mirabel M
    Eur Heart J; 2018 Oct; 39(38):3553. PubMed ID: 30107497
    [No Abstract]   [Full Text] [Related]  

  • 12. Ipilimumab may increase the severity of cutenaous toxicity related to radiotherapy.
    Eryılmaz MK; Mutlu H; Salim DK; Musri FY; Tural D; Başsorgun I; Coşkun HŞ
    J Oncol Pharm Pract; 2016 Jun; 22(3):533-6. PubMed ID: 25694346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HBV-related acute hepatitis due to immune checkpoint inhibitors in a patient with malignant melanoma.
    Koksal AS; Toka B; Eminler AT; Hacibekiroglu I; Uslan MI; Parlak E
    Ann Oncol; 2017 Dec; 28(12):3103-3104. PubMed ID: 28945827
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination Ipilimumab and Nivolumab for Metastatic Melanoma Associated With Ciliochoroidal Effusion and Exudative Retinal Detachment.
    Tsui E; Madu A; Belinsky I; Yannuzzi LA; Freund KB; Modi YS
    JAMA Ophthalmol; 2017 Dec; 135(12):1455-1457. PubMed ID: 29145556
    [No Abstract]   [Full Text] [Related]  

  • 15. Myocarditis as an immune-related adverse event with ipilimumab/nivolumab combination therapy for metastatic melanoma.
    Mehta A; Gupta A; Hannallah F; Koshy T; Reimold S
    Melanoma Res; 2016 Jun; 26(3):319-20. PubMed ID: 27110676
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute visual loss after ipilimumab treatment for metastatic melanoma.
    Wilson MA; Guld K; Galetta S; Walsh RD; Kharlip J; Tamhankar M; McGettigan S; Schuchter LM; Fecher LA
    J Immunother Cancer; 2016; 4():66. PubMed ID: 27777775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Mayo Clinic Experience With the Neurological Complications of the CTLA-4 Inhibitor Ipilimumab.
    Ruff MW; Mauermann ML
    Neurologist; 2018 May; 23(3):98-99. PubMed ID: 29722744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Digital ischaemia with fingertip ulcers during ipilimumab therapy].
    Zenati N; Charles J; Templier I; Blaise S
    Ann Dermatol Venereol; 2020 Mar; 147(3):212-216. PubMed ID: 31864764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acutely induced diabetes mellitus in a 63-year-old female after treatment with ipilimumab for metastatic melanoma].
    Jørgensen LB; Yderstræde K
    Ugeskr Laeger; 2017 Sep; 179(37):. PubMed ID: 28918779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypophysitis and other autoimmune complications related to immune checkpoints inhibitors´ treatment: Spectrum of imaging appearances.
    Malikova H; Holesta M; Fialova A; Arenbergerova M; Weichet J
    Neuro Endocrinol Lett; 2018 Sep; 39(3):196-204. PubMed ID: 30431741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.